Abb Ltd.-RegABLZF

13F holders, Q1 2026 (March 31)
1holders
0new positions
0sold out
$79.12avg. 13F price*

At the end of Q1 2026, 1 institutions reported holding Abb Ltd.-Reg (ABLZF) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Generali Investments CEE, investicni spolecnost, a.s. ($1.1M).

Company
Abb Ltd.-Reg
CUSIP
H0010V101
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 3Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q4 2025 → Q1 2026: 656 shares sold, net −656 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Generali Investments CEE, investicni spolecnost, a.s. 0.06% Reduce -4.4% 14,345 $1.1M

"% of holder's portfolio" is ABLZF's weight in each manager's 13F, not the share of Abb Ltd.-Reg the manager owns.